Lannett Launches Generic Diazepam Intensol

Lannett Company announced it has received FDA approval for its Abbreviated New Drug Application (ANDA) for Diazepam Oral Solution (Concentrate), the generic version of Roxane's Diazepam Intensol.

Diazepam oral solution, a Schedule IV controlled drug, is a concentrated benzodiazepine solution indicated for the treatment of anxiety, as adjunct treatment for skeletal muscle spasm, and as adjunct treatment in convulsive disorders.

RELATED: Psychiatric Disorders Resource Center

Diazepam Oral Solution (Concentrate) is available in a 5mg/mL strength.

For more information, call (215) 333-9000 or visit